We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Welltower Gears Up to Report Q3 Earnings: What's in the Cards?
Read MoreHide Full Article
Key Takeaways
WELL will report Q3 2025 results on Oct. 27, with expected year-over-year revenue and FFO per share gains.
An aging population, higher healthcare spending and limited new supply are likely to support the Q3 results.
Long-term leases and investment efforts bolster growth, though high interest expenses pose a drag.
Welltower, Inc. (WELL - Free Report) is slated to report third-quarter 2025 results on Oct. 27, after market close. The quarterly results are likely to reflect year-over-year growth in revenues and normalized funds from operations (FFO) per share.
In the last reported quarter, this Toledo, OH-based healthcare real estate investment trust (REIT) witnessed a normalized FFO per share of $1.28, beating the Zacks Consensus Estimate of $1.22. Results reflected a rise in revenues on a year-over-year basis. The total portfolio same-store net operating income (SSNOI) increased year over year, driven by SSNOI growth in the senior housing operating (SHO) portfolio.
Over the preceding four quarters, Welltower’s normalized FFO per share beat the Zacks Consensus Estimate on all occasions, the average beat being 4.22%. The graph below depicts this surprise history:
Welltower owns a diversified portfolio in the healthcare real estate industry in the major, high-growth markets of the United States, Canada and the U.K. During the third quarter, the company’s SHO portfolio is likely to have continued to benefit from an aging U.S. population and a rise in healthcare expenditure by this age cohort, which is usually on the higher end compared with the general population. In addition, muted new supply is expected to have provided a favorable operating environment for this portfolio.
Further, Welltower’s long-term leases with its healthcare management companies or operators are anticipated to have led to stable revenue generation, boosting its top line.
The Zacks Consensus Estimate for quarterly total revenues is pegged at $2.65 billion, suggesting an increase of 28.9% from the prior-year period’s reported number.
We expect WELL to have continued with its investment and development activities during the quarter, supported by its solid balance sheet position and capital-recycling efforts.
WELL’s activities during the quarter were adequate to garner analysts’ confidence. The Zacks Consensus Estimate for third-quarter normalized FFO per share has been revised a cent upward to $1.30 in the past week. The figure suggests an increase of 17.1% from the year-ago reported number.
However, high interest expenses are likely to have been a spoilsport for Welltower during the to-be-reported quarter.
What Our Quantitative Model Predicts
Our proven model does not conclusively predict a likely surprise in terms of FFO per share for Welltower this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the chances of an FFO beat, which is not the case here.
Welltower currently has an Earnings ESP of -0.14% and carries a Zacks Rank of 2. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks That Warrant a Look
Here are two stocks from the broader REIT industry — Ventas (VTR - Free Report) and Extra Space Storage (EXR - Free Report) — that you may want to consider, as our model shows that these have the right combination of elements to report a surprise this quarter.
EXR, scheduled to report quarterly numbers on Oct. 29, has an Earnings ESP of +0.23% and a Zacks Rank of 3.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Welltower Gears Up to Report Q3 Earnings: What's in the Cards?
Key Takeaways
Welltower, Inc. (WELL - Free Report) is slated to report third-quarter 2025 results on Oct. 27, after market close. The quarterly results are likely to reflect year-over-year growth in revenues and normalized funds from operations (FFO) per share.
In the last reported quarter, this Toledo, OH-based healthcare real estate investment trust (REIT) witnessed a normalized FFO per share of $1.28, beating the Zacks Consensus Estimate of $1.22. Results reflected a rise in revenues on a year-over-year basis. The total portfolio same-store net operating income (SSNOI) increased year over year, driven by SSNOI growth in the senior housing operating (SHO) portfolio.
Over the preceding four quarters, Welltower’s normalized FFO per share beat the Zacks Consensus Estimate on all occasions, the average beat being 4.22%. The graph below depicts this surprise history:
Welltower Inc. Price and EPS Surprise
Welltower Inc. price-eps-surprise | Welltower Inc. Quote
Factors at Play for WELL
Welltower owns a diversified portfolio in the healthcare real estate industry in the major, high-growth markets of the United States, Canada and the U.K. During the third quarter, the company’s SHO portfolio is likely to have continued to benefit from an aging U.S. population and a rise in healthcare expenditure by this age cohort, which is usually on the higher end compared with the general population. In addition, muted new supply is expected to have provided a favorable operating environment for this portfolio.
Further, Welltower’s long-term leases with its healthcare management companies or operators are anticipated to have led to stable revenue generation, boosting its top line.
The Zacks Consensus Estimate for quarterly total revenues is pegged at $2.65 billion, suggesting an increase of 28.9% from the prior-year period’s reported number.
We expect WELL to have continued with its investment and development activities during the quarter, supported by its solid balance sheet position and capital-recycling efforts.
WELL’s activities during the quarter were adequate to garner analysts’ confidence. The Zacks Consensus Estimate for third-quarter normalized FFO per share has been revised a cent upward to $1.30 in the past week. The figure suggests an increase of 17.1% from the year-ago reported number.
However, high interest expenses are likely to have been a spoilsport for Welltower during the to-be-reported quarter.
What Our Quantitative Model Predicts
Our proven model does not conclusively predict a likely surprise in terms of FFO per share for Welltower this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the chances of an FFO beat, which is not the case here.
Welltower currently has an Earnings ESP of -0.14% and carries a Zacks Rank of 2. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks That Warrant a Look
Here are two stocks from the broader REIT industry — Ventas (VTR - Free Report) and Extra Space Storage (EXR - Free Report) — that you may want to consider, as our model shows that these have the right combination of elements to report a surprise this quarter.
Ventas is slated to report quarterly numbers on Oct. 29. VTR has an Earnings ESP of +0.84% and carries a Zacks Rank of 3 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
EXR, scheduled to report quarterly numbers on Oct. 29, has an Earnings ESP of +0.23% and a Zacks Rank of 3.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.